Glycopath Inc
Diagnostics company · Charleston, South Carolina, United States
Glycopath Inc is a diagnostics company headquartered in Charleston, South Carolina, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $926,895 in total, most recently in 2023.
Glycopath at a glance
What does Glycopath do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $926,895 in total (2019 to 2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute.
Frequently asked questions about Glycopath
Where is Glycopath headquartered?
Glycopath Inc is headquartered in Charleston, South Carolina, United States.
What does Glycopath do?
Glycopath Inc is a diagnostics company.
Similar companies
- Circa Bioscience LLCCharleston, South Carolina, United States
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Visby Medical, Inc.San Jose, California, United States
- Lucira Health, Inc.Emeryville, California, United States
- NeuroTrack Technologies, Inc.Redwood City, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences